Most cited papers in Curcumin's Biomedical Applications
What are the most cited papers in Curcumin's Biomedical Applications?
The most cited paper in Curcumin's Biomedical Applications is "Bioavailability of Curcumin: Problems and Promises" (Preetha Anand, Ajaikumar Bahulayan Kunnumakkara, Robert Alan Newman et al., 2007), with 5,518 citations. Next come "Role of reactive oxygen species (ROS) in apoptosis induction" (2,787) and "Curcumin: A Review of Its Effects on Human Health" (2,687).
Showing 50 of 100 papers. Every paper with more than 679 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Bioavailability of Curcumin: Problems and Promises Preetha Anand, Ajaikumar Bahulayan Kunnumakkara, Robert Alan Newman et al. · Molecular Pharmaceutics | 14 Nov 2007 | 5,518 |
| 2 | Role of reactive oxygen species (ROS) in apoptosis induction Hans‐Uwe Simon, Abdulla Haj-Yehia, Francesca Levi‐Schaffer · APOPTOSIS | Nov 2000 | 2,787 |
| 3 | Curcumin: A Review of Its Effects on Human Health Susan Joyce Hewlings, Douglas Kalman · Foods | 22 Oct 2017 | 2,687 |
| 4 | Anticancer potential of curcumin: preclinical and clinical studies. Bharat Bhushan Aggarwal, Anushree Jai Kumar, Alok Chandra Bharti · PubMed | May 2003 | 2,576 |
| 5 | Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo Fusheng Yang, Giselle P. Lim, Aynun Nahar Begum et al. · Journal of Biological Chemistry | 8 Dec 2004 | 2,331 |
| 6 | Curcumin as “Curecumin”: From kitchen to clinic Ajay Goel, Ajaikumar Bahulayan Kunnumakkara, Bharat Bhushan Aggarwal · Biochemical Pharmacology | 20 Aug 2007 | 2,222 |
| 7 | Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials Subash C. Gupta, Sridevi Patchva, Bharat Bhushan Aggarwal · The AAPS Journal | 9 Nov 2012 | 2,109 |
| 8 | Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Ann‐Lii Cheng et al. · PubMed | 10 Dec 2001 | 2,081 |
| 9 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Bharat Bhushan Aggarwal, Kuzhuvelil B. Harikumar · The International Journal of Biochemistry & Cell Biology | 10 Jul 2008 | 2,037 |
| 10 | Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease David Allan Butterfield, Barry B. Halliwell · Nature reviews. Neuroscience | 8 Feb 2019 | 2,001 |
| 11 | Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers Guido Shoba, David C. Joy, Thangam Joseph et al. · Planta Medica | May 1998 | 1,970 |
| 12 | The Essential Medicinal Chemistry of Curcumin Kathryn M. Nelson, Jayme L. Dahlin, Jonathan Bisson et al. · Journal of Medicinal Chemistry | 11 Jan 2017 | 1,950 |
| 13 | Antioxidant and radical scavenging properties of curcumin Tuba Parlak Ak, İlhami Gülçın · Chemico-Biological Interactions | 8 May 2008 | 1,941 |
| 14 | Curcumin: From ancient medicine to current clinical trials Heather Hatcher, Roy P. Planalp, J. Cho et al. · Cellular and Molecular Life Sciences | 6 Mar 2008 | 1,860 |
| 15 | Gasdermin E suppresses tumour growth by activating anti-tumour immunity Zhibin Zhang, Ying Zhang, Shiyu Xia et al. · Nature | 11 Mar 2020 | 1,791 |
| 16 | Molecular targets of dietary agents for prevention and therapy of cancer Bharat Bhushan Aggarwal, Shishir Shishodia · Biochemical Pharmacology | 24 Feb 2006 | 1,761 |
| 17 | Stability of curcumin in buffer solutions and characterization of its degradation products Ying‐Jan Wang, Min‐Hsiung Pan, Ann‐Lii Cheng et al. · Journal of Pharmaceutical and Biomedical Analysis | Aug 1997 | 1,707 |
| 18 | Pharmacology of Curcuma longa Hermann P. T. Ammon, Martin Wahl · Planta Medica | Feb 1991 | 1,690 |
| 19 | Multiple biological activities of curcumin: A short review Radha K. Maheshwari, Anoop K. Singh, Jaya P. Gaddipati et al. · Life Sciences | 19 Jan 2006 | 1,670 |
| 20 | Curcumin: The story so far Ricky A. Sharma, Andreas J. Gescher, William P. Steward · European Journal of Cancer | 4 Aug 2005 | 1,657 |
| 21 | CURCUMIN: THE INDIAN SOLID GOLD Bharat Bhushan Aggarwal, Chitra Sundaram, Nikita Malani et al. · Advances in experimental medicine and biology | 6 Aug 2007 | 1,654 |
| 22 | Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation Young‐Joon Surh, Kyung‐Soo Chun, Hyun-Ho Cha et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis | Sep 2001 | 1,625 |
| 23 | A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes Dongmei Sun, Xiaoying Zhuang, Xiaoyu Xiang et al. · Molecular Therapy | 22 Jun 2010 | 1,582 |
| 24 | The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse Giselle P. Lim, Teresa Chu, Fusheng Yang et al. · Journal of Neuroscience | Nov 2001 | 1,534 |
| 25 | The Chemistry of Curcumin: From Extraction to Therapeutic Agent Kavirayani Indira Priyadarsini · Molecules | Dec 2014 | 1,506 |
| 26 | Dose escalation of a curcuminoid formulation Christopher D. Lao, Mack T. Ruffin, Daniel Paul Normolle et al. · BMC Complementary and Alternative Medicine | 17 Mar 2006 | 1,398 |
| 27 | ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN Venugopal Padmanabhan Menon, Adluri Ram Sudheer · Advances in experimental medicine and biology | 6 Aug 2007 | 1,398 |
| 28 | Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) Sanjaya Singh, Bharat Bhushan Aggarwal · Journal of Biological Chemistry | Oct 1995 | 1,389 |
| 29 | Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain Xiaoying Zhuang, Xiaoyu Xiang, William E. Grizzle et al. · Molecular Therapy | 13 Sep 2011 | 1,361 |
| 30 | Molecular mechanisms of N -acetylcysteine actions Muhammad Zafarullah, W. Q. Li, Judith Sylvester et al. · Cellular and Molecular Life Sciences | 2003 | 1,345 |
| 31 | Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer Navneet Kaur Dhillon, Bharat Bhushan Aggarwal, Robert Alan Newman et al. · Clinical Cancer Research | 15 Jul 2008 | 1,333 |
| 32 | Oxidative stress and apoptosis Krishnaswamy Kannan, Sushil Kumar Jain · Pathophysiology | Sep 2000 | 1,297 |
| 33 | A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin Soheil Zorofchian Moghadamtousi, Habsah Abdul Kadir, Pouya Hassandarvish et al. · BioMed Research International | 2014 | 1,272 |
| 34 | The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications Jinhuan Jiang, Jiang Pi, Jiye Cai · Bioinorganic Chemistry and Applications | 5 Jul 2018 | 1,262 |
| 35 | Phase I Clinical Trial of Oral Curcumin Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · Clinical Cancer Research | 15 Oct 2004 | 1,259 |
| 36 | Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro Kenjiro Ono, Kazuhiro Hasegawa, Hironobu Naiki et al. · Journal of Neuroscience Research | 13 Feb 2004 | 1,254 |
| 37 | Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Julie S Jurenka · PubMed | Jun 2009 | 1,220 |
| 38 | Curcumin, an active component of turmeric ( Curcuma longa ), and its effects on health Betül Kocaadam Bozkurt, Nevin Şanlıer · Critical Reviews in Food Science and Nutrition | 3 Nov 2015 | 1,212 |
| 39 | Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature Preetha Anand, Sherin G. Thomas, Ajaikumar Bahulayan Kunnumakkara et al. · Biochemical Pharmacology | 20 Aug 2008 | 1,208 |
| 40 | Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets Bharat Bhushan Aggarwal, Bokyung Sung · Trends in Pharmacological Sciences | 27 Dec 2008 | 1,146 |
| 41 | Nitric Oxide Scavenging by Curcuminoids Sreejayan, Mahadev Rao · Journal of Pharmacy and Pharmacology | 1997 | 1,137 |
| 42 | Curcumin and cancer: An “old-age” disease with an “age-old” solution Preetha Anand, Chitra Sundaram, Sonia Jhurani et al. · Cancer Letters | 7 May 2008 | 1,135 |
| 43 | Oxygen radical scavenging activity of curcumin Elizabeth Kunchandy, Mahadev Rao · International Journal of Pharmaceutics | Feb 1990 | 1,131 |
| 44 | Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric ( Curcuma longa ) Nita Chainani‐Wu · The Journal of Alternative and Complementary Medicine | Feb 2003 | 1,105 |
| 45 | Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy Savita Bisht, Georg Feldmann, Sheetal Soni et al. · Journal of Nanobiotechnology | 17 Apr 2007 | 1,094 |
| 46 | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Ajaikumar Bahulayan Kunnumakkara, Preetha Anand, Bharat Bhushan Aggarwal · Cancer Letters | 14 May 2008 | 1,083 |
| 47 | Flavonoids as Potential Anti-Inflammatory Molecules: A Review Jameel Mohammed Al-Khayri, Gandasi Ravikumar Sahana, Praveen Nagella et al. · Molecules | 2 May 2022 | 1,082 |
| 48 | Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights Into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action Mithun Rudrapal, Shubham Jagadish Khairnar, Johra Khan et al. · Frontiers in Pharmacology | 14 Feb 2022 | 1,077 |
| 49 | Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Reason Wilken, Mysore S. Veena, Marilene B. Wang et al. · Molecular Cancer | 7 Feb 2011 | 1,073 |
| 50 | Anti-tumour and antioxidant activity of natural curcuminoids A.J. Ruby, Girija Kuttan, Kalapala Vijay Babu et al. · Cancer Letters | Jul 1995 | 1,071 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.